Description

Sitagliptin Phosphate Tablets (Nobetan) are formulated with 100mg of sitagliptin per tablet, a selective dipeptidyl peptidase-4 (DPP-4) inhibitor. Manufactured by Zhejiang Nuod Pharma Co., Ltd., this formulation is intended exclusively for experimental or research applications in metabolic disease and glucose regulation.

Each box includes 8 blister packs of 7 tablets, totaling 56 tablets per unit, making it suitable for extended research periods in type 2 diabetes models or DPP-4 inhibition studies.

?? This product is not for human use. It is strictly intended for research and laboratory settings.

Sitagliptin Phosphate Product Parameters

Sitagliptin Phosphate Mechanism & Research Applications

Sitagliptin works by inhibiting DPP-4, an enzyme responsible for the degradation of incretin hormones. This leads to enhanced glucose-dependent insulin secretion and decreased glucagon levels, thereby improving glycemic control.

In research, Sitagliptin Phosphate is utilized for:

• Studying DPP-4 enzyme inhibition

• Simulating type 2 diabetes treatment models

• Evaluating glucose homeostasis and pancreatic beta-cell function

• Combination therapy research with metformin or SGLT2 inhibitors

Sitagliptin Phosphate Observed Research Outcomes

• Lower fasting plasma glucose levels

• Increased active GLP-1 concentrations

• Reduced postprandial hyperglycemia

• Preservation of beta-cell function in animal models

Safety & Handling

• For research use only, not for human or veterinary administration

• Store at room temperature in a dry, dark environment

• Use appropriate protective equipment when handling

• Follow standard lab disposal protocols

Research Use Disclaimer

This product is distributed solely for research and laboratory use. It is not approved for therapeutic, diagnostic, or clinical use in humans or animals.